Literature DB >> 3210248

Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone.

L G Herbette1, M Trumbore, D W Chester, A M Katz.   

Abstract

The interactions of propranolol, nimodipine, and amiodarone with membrane lipids were examined in an effort to explain their different pharmacokinetic and pharmacodynamic properties. Propranolol and nimodipine, which bind with high affinity to plasmalemmal beta-adrenergic and calcium channel receptors, respectively, have membrane partition coefficients of approximately 1200 and 5000 and are readily washed out of membranes with which they had been equilibrated. X-ray and neutron diffraction studies showed that after partitioning into lipid membranes, both propranolol and nimodipine are located approximately 6 A from the phosphate headgroup region of the membrane bilayer, near the hydrocarbon core/water interface. Amiodarone, which blocks Na and K channels with less site specificity than propranolol and nimodipine, has a much higher partition coefficient of approximately 1,000,000, resists washout from membrane bilayers, and is located deeper in the membrane, approximately 12 A from the phosphate headgroup region of the bilayer, nearer to the terminal methyl groups of the fatty acyl chains. The shorter durations of clinical action of propranolol and nimodipine may be related to the reversibility of their interactions with the region of the bilayer exposed to the aqueous media near the hydrocarbon core/water interface, whereas the much longer duration of clinical action of amiodarone may reflect a location more deeply within the fatty acyl region of the bilayer where this hydrophobic drug interacts avidly with the hydrocarbon core of the membrane.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3210248     DOI: 10.1016/s0022-2828(88)80128-7

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  14 in total

1.  The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trapping.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

Review 2.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Morphological Effects Induced In Vitro by Propranolol on Human Erythrocytes.

Authors:  Mario Suwalsky; Pablo Zambrano; Fernando Villena; Marcela Manrique-Moreno; María José Gallardo; Malgorzata Jemiola-Rzeminska; Kazimierz Strzalka; Ana María Edwards; Sigrid Mennickent; Nathan Dukes
Journal:  J Membr Biol       Date:  2015-02-28       Impact factor: 1.843

Review 4.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.

Authors:  P Chatelain; L Meysmans; J R Mattéazzi; P Beaufort; M Clinet
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone.

Authors:  Lydie Maresova; Sabina Muend; Yong-Qiang Zhang; Hana Sychrova; Rajini Rao
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

7.  Anticonvulsant and hypnotic effects of amiodarone.

Authors:  Gunnur Ozbakis-Dengiz; Aysegul Bakirci
Journal:  J Zhejiang Univ Sci B       Date:  2009-04       Impact factor: 3.066

8.  Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.

Authors:  A T Nials; M J Sumner; M Johnson; R A Coleman
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.

Authors:  I K Pajeva; M Wiese; H P Cordes; J K Seydel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

10.  Dynamic Protonation Dramatically Affects the Membrane Permeability of Drug-like Molecules.

Authors:  Zhi Yue; Chenghan Li; Gregory A Voth; Jessica M J Swanson
Journal:  J Am Chem Soc       Date:  2019-08-16       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.